|
97
|
Safety Signal of Azithromycin and the Risk of Myocarditis
|
|
Signal
|
|
|
96
|
Safety Signal of Dulaglutide and the Risk of Alopecia
|
|
Signal
|
|
|
95
|
Safety Signal of Panitumumab and the Risk of Panniculitis
|
|
Signal
|
|
|
94
|
Safety Signal of Teriparatide and the Risk of Shivering
|
|
Signal
|
|
|
93
|
Safety Signal of Natalizumab and the Risk of Acute Coronary Syndrome
|
|
Signal
|
|
|
92
|
Safety Signal of Imatinib and the Risk of Polyserositis
|
|
Signal
|
|
|
91
|
Safety Signal of Donepezil and the Risk of QT prolongation
|
|
Signal
|
|
|
89
|
Safety Signal of Dolutegravir and the Risk of Hyperglycemia
|
|
Signal
|
|
|
88
|
Safety Signal of Clopidogrel and the Risk of Hypertension
|
|
Signal
|
|
|
87
|
Safety Signal of Agomelatine and the Risk of Hypertension
|
|
Signal
|
|
